Total Valuation
Profarma Distribuidora de Produtos Farmaceuticos SA has a market cap or net worth of R$848.47M. The enterprise value is R$2.49K.
Market CapR$848.47M
Enterprise ValueR$2.49K
Share Statistics
Profarma Distribuidora de Produtos Farmaceuticos SA has 123,812,775 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding123,812,775
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Profarma Distribuidora de Produtos Farmaceuticos SA’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 12.01%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)12.01%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee1.62M
Profits Per Employee16.80K
Employee Count7,077
Asset Turnover1.84
Inventory Turnover4.63
Valuation Ratios
The current PE Ratio of Profarma Distribuidora de Produtos Farmaceuticos SA is 5.5. Profarma Distribuidora de Produtos Farmaceuticos SA’s PEG ratio is 2.19.
PE Ratio5.5
PS Ratio0.10
PB Ratio0.83
Price to Fair Value0.83
Price to FCF5.89
Price to Operating Cash Flow1.84
PEG Ratio2.19
Income Statement
In the last 12 months, Profarma Distribuidora de Produtos Farmaceuticos SA had revenue of 11.45B and earned 118.90M in profits. Earnings per share was 0.97.
Revenue11.45B
Gross Profit1.75B
Operating Income381.63M
Pretax Income117.46M
Net Income118.90M
EBITDA581.79M
Earnings Per Share (EPS)0.97
Cash Flow
In the last 12 months, operating cash flow was 460.53M and capital expenditures -163.48M, giving a free cash flow of 297.06M billion.
Operating Cash Flow460.53M
Free Cash Flow297.06M
Free Cash Flow per Share2.40
Dividends & Yields
Profarma Distribuidora de Produtos Farmaceuticos SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.03
52-Week Price Change2.91%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)128.09K
Important Dates
Profarma Distribuidora de Produtos Farmaceuticos SA upcoming earnings date is Oct 28, 2026, After Close (Confirmed).
Last Earnings DateJul 29, 2026
Next Earnings DateOct 28, 2026
Ex-Dividend Date―
Financial Position
Profarma Distribuidora de Produtos Farmaceuticos SA as a current ratio of 1.29, with Debt / Equity ratio of 131.54%
Current Ratio1.29
Quick Ratio0.69
Debt to Market Cap0.78
Net Debt to EBITDA2.01
Interest Coverage Ratio1.81
Taxes
In the past 12 months, Profarma Distribuidora de Produtos Farmaceuticos SA has paid -8.55M in taxes.
Income Tax-8.55M
Effective Tax Rate-0.07
Enterprise Valuation
Profarma Distribuidora de Produtos Farmaceuticos SA EV to EBITDA ratio is 3.93, with an EV/FCF ratio of 12.02.
EV to Sales0.20
EV to EBITDA3.93
EV to Free Cash Flow12.02
EV to Operating Cash Flow6.79
Balance Sheet
Profarma Distribuidora de Produtos Farmaceuticos SA has R$487.77M in cash and marketable securities with R$1.90B in debt, giving a net cash position of -R$1.41B billion.
Cash & Marketable SecuritiesR$487.77M
Total DebtR$1.90B
Net Cash-R$1.41B
Net Cash Per Share-R$11.39
Tangible Book Value Per ShareR$8.15
Margins
Gross margin is 15.14%, with operating margin of 3.33%, and net profit margin of 1.04%.
Gross Margin15.14%
Operating Margin3.33%
Pretax Margin1.03%
Net Profit Margin1.04%
EBITDA Margin5.08%
EBIT Margin3.33%
Analyst Forecast
The average price target for Profarma Distribuidora de Produtos Farmaceuticos SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast13.20%
EPS Growth Forecast30.95%